Income inequality as a determinant of neonatal mortality in the Americas during 2000-2019: implications for the attainment of Sustainable Development Goal target 3.2.

BACKGROUND: The work of the WHO Commission on the Social Determinants of Health has been fundamental to provide a conceptual framework of the social determinants of health. Based on this framework, this study assesses the relationship of income inequality as a determinant of neonatal mortality in the Americas and relates it to the achievement of the Sustainable Development Goal target 3.2 (reduce neonatal mortality to at least as low as 12 deaths per 1,000 live births). The rationale is to evaluate if income inequality may be considered a social factor that influences neonatal mortality in the Americas. METHODS: Yearly data from 35 countries in the Americas during 2000-2019 was collected. Data sources include the United Nations Inter-agency Group for Child Mortality Estimation for the neonatal mortality rate (measured as neonatal deaths per 1,000 live births) and the United Nations University World Institute for Development Economics Research for the Gini index (measured in a scale from 0 to 100). This is an ecological study that employs a linear regression model that relates the neonatal mortality rate (dependent variable) to the Gini index (independent variable), while controlling for other factors that influence neonatal mortality. Coefficient estimates and their robust standard errors were obtained using panel data techniques. RESULTS: A positive relationship between income inequality and neonatal mortality is found in countries in the Americas during the period studied. In particular, the analysis suggests that a unit increase in a country's Gini index during 2000-2019 is associated with a 0.27 (95% CI [- 0.04, 0.57], P =.09) increase in the neonatal mortality rate. CONCLUSION: The analysis suggests that income inequality may be positively associated with the neonatal mortality rate in the Americas. Nonetheless, given the modest magnitude of the estimates and Gini values and trends during 2000-2019, the findings suggest a potential limited scope for redistributive policies to support reductions in neonatal mortality in the region. Thus, policies and interventions that address higher coverage and quality of services provided by national health systems and reductions in socio-economic inequalities in health are of utmost importance.

Neonatal mortality in countries of the Americas, 2000-2020: trends, inequalities, and target-setting.

Objective: To analyze temporal trends and inequalities in neonatal mortality between 2000 and 2020, and to set neonatal mortality targets for 2025 and 2030 in the Americas. Methods: A descriptive ecological study was conducted using 33 countries of the Americas as units of analysis. Both the percentage change and average annual percentage change in neonatal mortality rates were estimated. Measurements of absolute and relative inequality based on adjusted regression models were used to assess cross-country social inequalities in neonatal mortality. Targets to reduce neonatal mortality and cross-country inequalities were set for 2025 and 2030. Results: The estimated regional neonatal mortality rate was 12.0 per 1 000 live births in 2000-2004 and 7.4 per 1 000 live births in 2020, representing a percentage change of -38.3% and an average annual percentage change of -2.7%. National average annual percentage changes in neonatal mortality rates between 2000-2004 and 2020 ranged from -5.5 to 1.9 and were mostly negative. The estimated excess neonatal mortality in the 20% most socially disadvantaged countries, compared with the 20% least socially disadvantaged countries, was 17.1 and 9.8 deaths per 1 000 live births in 2000-2004 and 2020, respectively. Based on an extrapolation of recent trends, the regional neonatal mortality rate is projected to reach 7.0 and 6.6 neonatal deaths per 1 000 live births by 2025 and 2030, respectively. Conclusions: National and regional health authorities need to strengthen their efforts to reduce persistent social inequalities in neonatal mortality both within and between countries.

Neonatal mortality in countries of the Americas, 2000–2020: trends, inequalities, and target-setting / Mortalidad neonatal en los países de la Región de las Américas, 2000-2020: tendencias, desigualdades y establecimiento de metas / Mortalidade neonatal nos países das Américas, 2000-2020: tendências, desigualdades e definição de metas

[ABSTRACT]. Objective. To analyze temporal trends and inequalities in neonatal mortality between 2000 and 2020, and to set neonatal mortality targets for 2025 and 2030 in the Americas. Methods. A descriptive ecological study was conducted using 33 countries of the Americas as units of anal- ysis. Both the percentage change and average annual percentage change in neonatal mortality rates were estimated. Measurements of absolute and relative inequality based on adjusted regression models were used to assess cross-country social inequalities in neonatal mortality. Targets to reduce neonatal mortality and cross-country inequalities were set for 2025 and 2030. Results. The estimated regional neonatal mortality rate was 12.0 per 1 000 live births in 2000–2004 and 7.4 per 1 000 live births in 2020, representing a percentage change of –38.3% and an average annual per- centage change of –2.7%. National average annual percentage changes in neonatal mortality rates between 2000–2004 and 2020 ranged from –5.5 to 1.9 and were mostly negative. The estimated excess neonatal mor- tality in the 20% most socially disadvantaged countries, compared with the 20% least socially disadvantaged countries, was 17.1 and 9.8 deaths per 1 000 live births in 2000–2004 and 2020, respectively. Based on an extrapolation of recent trends, the regional neonatal mortality rate is projected to reach 7.0 and 6.6 neonatal deaths per 1 000 live births by 2025 and 2030, respectively. Conclusions. National and regional health authorities need to strengthen their efforts to reduce persistent social inequalities in neonatal mortality both within and between countries.

[RESUMEN]. Objetivo. Analizar las desigualdades en la mortalidad neonatal y las tendencias en el transcurso del tiempo entre el 2000 y el 2020, y establecer metas en materia de mortalidad neonatal para el 2025 y el 2030 en la Región de las Américas. Métodos. Se realizó un estudio ecológico descriptivo con información de 33 países de la Región de las Américas que se usaron como unidades de análisis. Se calculó tanto la variación porcentual como la varia- ción porcentual anual media de las tasas de mortalidad neonatal. Se utilizaron mediciones de la desigualdad absoluta y relativa basadas en modelos de regresión ajustados, para evaluar las desigualdades sociales en los diversos países en cuanto a la mortalidad neonatal. Se establecieron metas de reducción de la mortalidad neonatal y de las desigualdades en los diversos países para el 2025 y el 2030. Resultados. La tasa de mortalidad neonatal en la Región fue de 12,0 por 1 000 nacidos vivos en el período 2000-2004 y de 7,4 por 1 000 nacidos vivos en el 2020, lo que representa una variación porcentual del –38,3% y una variación porcentual anual media del –2,7%. Las variaciones porcentuales anuales medias de las tasas de mortalidad neonatal a nivel nacional entre el período 2000-2004 y el 2020 oscilaron entre –5,5 y 1,9, y fueron en su mayor parte negativas. El exceso de mortalidad neonatal estimado en el 20% de los países más desfavorecidos socialmente, en comparación con el 20% de los países menos desfavorecidos socialmente, fue de 17,1 muertes por 1 000 nacidos vivos en el período 2000-2004 y de 9,8 muertes por 1 000 nacidos vivos en el 2020. Al extrapolar las tendencias más recientes, se prevé que la tasa de mortalidad neonatal de la Región alcance valores de 7,0 y 6,6 muertes neonatales por 1 000 nacidos vivos en el 2025 y el 2030, respectivamente. Conclusiones. Las autoridades de salud nacionales y regionales deben fortalecer las medidas para reducir las desigualdades sociales que aún persisten en materia de mortalidad neonatal, tanto entre los distintos países como dentro de cada país.

[RESUMO]. Objetivo. Analisar as tendências temporais e desigualdades em mortalidade neonatal entre 2000 e 2020 e estabelecer metas de mortalidade neonatal para 2025 e 2030 na Região das Américas. Métodos. Estudo ecológico descritivo examinando 33 países das Américas como unidades de análise. Foram estimadas a variação percentual e a variação percentual anual média das taxas de mortalidade neonatal. Foram usadas medidas de desigualdade absoluta e relativa baseadas em modelos de regressão ajustados para avaliar desigualdades sociais entre países em termos de mortalidade neonatal. Foram definidas metas de redução da mortalidade neonatal e das desigualdades entre países para 2025 e 2030. Resultados. A taxa regional estimada de mortalidade neonatal foi de 12,0 por mil nascidos vivos em 2000– 2004, e de 7,4 por mil nascidos vivos em 2020, representando uma variação percentual de -38,3%, e uma variação percentual anual média de -2,7%. As variações percentuais anuais médias nacionais das taxas de mortalidade neonatal entre 2000–2004 e 2020 variaram entre -5,5 e 1,9 e, em sua maioria, foram negativas. O excesso estimado de mortalidade neonatal nos países que estavam entre os 20% mais desfavorecidos socialmente, em comparação com os países entre os 20% menos desfavorecidos, foi de 17,1 e 9,8 mortes por mil nascidos vivos em 2000–2004 e 2020, respectivamente. Com base em extrapolação das tendências recentes, estima-se que a taxa de mortalidade neonatal regional deve atingir 7,0 e 6,6 mortes neonatais por mil nascidos vivos em 2025 e 2030, respectivamente. Conclusões. As autoridades de saúde nacionais e regionais precisam intensificar seus esforços para reduzir desigualdades sociais persistentes na mortalidade neonatal, tanto dentro dos países quanto entre eles.

Neonatal mortality in countries of the Americas, 2000-2020: trends, inequalities, and target-setting / Mortalidad neonatal en los países de la Región de las Américas, 2000-2020: tendencias, desigualdades y establecimiento de metas / Mortalidade neonatal nos países das Américas, 2000-2020: tendências, desigualdades e definição de metas

ABSTRACT Objective. To analyze temporal trends and inequalities in neonatal mortality between 2000 and 2020, and to set neonatal mortality targets for 2025 and 2030 in the Americas. Methods. A descriptive ecological study was conducted using 33 countries of the Americas as units of analysis. Both the percentage change and average annual percentage change in neonatal mortality rates were estimated. Measurements of absolute and relative inequality based on adjusted regression models were used to assess cross-country social inequalities in neonatal mortality. Targets to reduce neonatal mortality and cross-country inequalities were set for 2025 and 2030. Results. The estimated regional neonatal mortality rate was 12.0 per 1 000 live births in 2000-2004 and 7.4 per 1 000 live births in 2020, representing a percentage change of -38.3% and an average annual percentage change of -2.7%. National average annual percentage changes in neonatal mortality rates between 2000-2004 and 2020 ranged from -5.5 to 1.9 and were mostly negative. The estimated excess neonatal mortality in the 20% most socially disadvantaged countries, compared with the 20% least socially disadvantaged countries, was 17.1 and 9.8 deaths per 1 000 live births in 2000-2004 and 2020, respectively. Based on an extrapolation of recent trends, the regional neonatal mortality rate is projected to reach 7.0 and 6.6 neonatal deaths per 1 000 live births by 2025 and 2030, respectively. Conclusions. National and regional health authorities need to strengthen their efforts to reduce persistent social inequalities in neonatal mortality both within and between countries.

RESUMEN Objetivo. Analizar las desigualdades en la mortalidad neonatal y las tendencias en el transcurso del tiempo entre el 2000 y el 2020, y establecer metas en materia de mortalidad neonatal para el 2025 y el 2030 en la Región de las Américas. Métodos. Se realizó un estudio ecológico descriptivo con información de 33 países de la Región de las Américas que se usaron como unidades de análisis. Se calculó tanto la variación porcentual como la variación porcentual anual media de las tasas de mortalidad neonatal. Se utilizaron mediciones de la desigualdad absoluta y relativa basadas en modelos de regresión ajustados, para evaluar las desigualdades sociales en los diversos países en cuanto a la mortalidad neonatal. Se establecieron metas de reducción de la mortalidad neonatal y de las desigualdades en los diversos países para el 2025 y el 2030. Resultados. La tasa de mortalidad neonatal en la Región fue de 12,0 por 1 000 nacidos vivos en el período 2000-2004 y de 7,4 por 1 000 nacidos vivos en el 2020, lo que representa una variación porcentual del -38,3% y una variación porcentual anual media del -2,7%. Las variaciones porcentuales anuales medias de las tasas de mortalidad neonatal a nivel nacional entre el período 2000-2004 y el 2020 oscilaron entre -5,5 y 1,9, y fueron en su mayor parte negativas. El exceso de mortalidad neonatal estimado en el 20% de los países más desfavorecidos socialmente, en comparación con el 20% de los países menos desfavorecidos socialmente, fue de 17,1 muertes por 1 000 nacidos vivos en el período 2000-2004 y de 9,8 muertes por 1 000 nacidos vivos en el 2020. Al extrapolar las tendencias más recientes, se prevé que la tasa de mortalidad neonatal de la Región alcance valores de 7,0 y 6,6 muertes neonatales por 1 000 nacidos vivos en el 2025 y el 2030, respectivamente. Conclusiones. Las autoridades de salud nacionales y regionales deben fortalecer las medidas para reducir las desigualdades sociales que aún persisten en materia de mortalidad neonatal, tanto entre los distintos países como dentro de cada país.

RESUMO Objetivo. Analisar as tendências temporais e desigualdades em mortalidade neonatal entre 2000 e 2020 e estabelecer metas de mortalidade neonatal para 2025 e 2030 na Região das Américas. Métodos. Estudo ecológico descritivo examinando 33 países das Américas como unidades de análise. Foram estimadas a variação percentual e a variação percentual anual média das taxas de mortalidade neonatal. Foram usadas medidas de desigualdade absoluta e relativa baseadas em modelos de regressão ajustados para avaliar desigualdades sociais entre países em termos de mortalidade neonatal. Foram definidas metas de redução da mortalidade neonatal e das desigualdades entre países para 2025 e 2030. Resultados. A taxa regional estimada de mortalidade neonatal foi de 12,0 por mil nascidos vivos em 2000-2004, e de 7,4 por mil nascidos vivos em 2020, representando uma variação percentual de -38,3%, e uma variação percentual anual média de -2,7%. As variações percentuais anuais médias nacionais das taxas de mortalidade neonatal entre 2000-2004 e 2020 variaram entre -5,5 e 1,9 e, em sua maioria, foram negativas. O excesso estimado de mortalidade neonatal nos países que estavam entre os 20% mais desfavorecidos socialmente, em comparação com os países entre os 20% menos desfavorecidos, foi de 17,1 e 9,8 mortes por mil nascidos vivos em 2000-2004 e 2020, respectivamente. Com base em extrapolação das tendências recentes, estima-se que a taxa de mortalidade neonatal regional deve atingir 7,0 e 6,6 mortes neonatais por mil nascidos vivos em 2025 e 2030, respectivamente. Conclusões. As autoridades de saúde nacionais e regionais precisam intensificar seus esforços para reduzir desigualdades sociais persistentes na mortalidade neonatal, tanto dentro dos países quanto entre eles.

Equity throughout the life course and the evolving role of the Pan American Health Organization.

The objective of this article is to summarize the evolution of the regional commitments of the Pan American Health Organization (PAHO) on health promotion and strategies to improve the health and well-being of women, children, adolescents, and older persons. PAHO regional strategies approved by Member States in the last 20 years are used as the main source of information. The article presents the challenges of making health promotion a public health strategy widely applied in the Region of the Americas and the efforts to renew Member States' collective actions. The article also describes current PAHO efforts to include the positive aspects of health (i.e., well-being, optimal development, and functional ability) and the life course approach as opportunities to advance equity. The article reflects on immunization as a public good and the urgency to address the current challenges as a core element of the regional efforts to transform health systems after more than two years of the COVID-19 pandemic.

El objetivo de este artículo es resumir la evolución de los compromisos regionales de la Organización Panamericana de la Salud (OPS) en materia de promoción de la salud y estrategias para mejorar la salud y el bienestar de mujeres, niños y niñas, adolescentes y personas mayores. Se han empleado como principal fuente de información las estrategias regionales de la OPS aprobadas por los Estados Miembros en los últimos 20 años. En el artículo se presentan los desafíos de convertir la promoción de la salud en una estrategia de salud pública de amplia ejecución en la Región de las Américas y los esfuerzos para renovar las medidas colectivas de los Estados Miembros. Asimismo, se describe la labor actual de la OPS para incluir los aspectos positivos de la salud (como el bienestar, el desarrollo óptimo y la capacidad funcional) y el enfoque del curso de vida como oportunidades para fomentar la equidad. Finalmente, se reflexiona sobre la inmunización como bien público y la urgencia de abordar los desafíos actuales como elemento central de los esfuerzos regionales para transformar los sistemas de salud tras más de dos años de pandemia de COVID-19.

O objetivo deste artigo é resumir a evolução dos compromissos regionais da Organização Pan-Americana da Saúde (OPAS) relativos à promoção da saúde e estratégias para melhorar a saúde e o bem-estar de mulheres, crianças, adolescentes e pessoas idosas. As estratégias regionais da OPAS aprovadas pelos Estados Membros nos últimos 20 anos são a principal fonte de informação. O artigo apresenta os desafios enfrentados para fazer da promoção da saúde uma estratégia de saúde pública amplamente aplicada na Região das Américas e os esforços para renovar as ações coletivas dos Estados Membros. O artigo também descreve os atuais esforços da OPAS para incluir os aspectos positivos da saúde (isto é, bem-estar, desenvolvimento ideal e habilidade funcional) e a abordagem de curso da vida como oportunidades para promover a equidade. O artigo faz reflexões sobre a imunização como um bem público e a urgência de abordar os desafios atuais como um elemento central dos esforços regionais para transformar os sistemas de saúde após mais de dois anos da pandemia de COVID-19.

Equity throughout the life course and the evolving role of the Pan American Health Organization

[ABSTRACT]. The objective of this article is to summarize the evolution of the regional commitments of the Pan Ameri- can Health Organization (PAHO) on health promotion and strategies to improve the health and well-being of women, children, adolescents, and older persons. PAHO regional strategies approved by Member States in the last 20 years are used as the main source of information. The article presents the challenges of making health promotion a public health strategy widely applied in the Region of the Americas and the efforts to renew Member States’ collective actions. The article also describes current PAHO efforts to include the positive aspects of health (i.e., well-being, optimal development, and functional ability) and the life course approach as opportunities to advance equity. The article reflects on immunization as a public good and the urgency to address the current challenges as a core element of the regional efforts to transform health systems after more than two years of the COVID-19 pandemic.

[RESUMEN]. El objetivo de este artículo es resumir la evolución de los compromisos regionales de la Organización Pan- americana de la Salud (OPS) en materia de promoción de la salud y estrategias para mejorar la salud y el bienestar de mujeres, niños y niñas, adolescentes y personas mayores. Se han empleado como principal fuente de información las estrategias regionales de la OPS aprobadas por los Estados Miembros en los últi- mos 20 años. En el artículo se presentan los desafíos de convertir la promoción de la salud en una estrategia de salud pública de amplia ejecución en la Región de las Américas y los esfuerzos para renovar las medidas colectivas de los Estados Miembros. Asimismo, se describe la labor actual de la OPS para incluir los aspectos positivos de la salud (como el bienestar, el desarrollo óptimo y la capacidad funcional) y el enfoque del curso de vida como oportunidades para fomentar la equidad. Finalmente, se reflexiona sobre la inmunización como bien público y la urgencia de abordar los desafíos actuales como elemento central de los esfuerzos regio- nales para transformar los sistemas de salud tras más de dos años de pandemia de COVID-19.

[RESUMO]. O objetivo deste artigo é resumir a evolução dos compromissos regionais da Organização Pan-Americana da Saúde (OPAS) relativos à promoção da saúde e estratégias para melhorar a saúde e o bem-estar de mulheres, crianças, adolescentes e pessoas idosas. As estratégias regionais da OPAS aprovadas pelos Estados Membros nos últimos 20 anos são a principal fonte de informação. O artigo apresenta os desafios enfrentados para fazer da promoção da saúde uma estratégia de saúde pública amplamente aplicada na Região das Américas e os esforços para renovar as ações coletivas dos Estados Membros. O artigo também descreve os atuais esforços da OPAS para incluir os aspectos positivos da saúde (isto é, bem-estar, desenvolvimento ideal e habilidade funcional) e a abordagem de curso da vida como oportunidades para promover a equidade. O artigo faz reflexões sobre a imunização como um bem público e a urgência de abordar os desafios atuais como um elemento central dos esforços regionais para transformar os sistemas de saúde após mais de dois anos da pandemia de COVID-19.

[Strategies for health services in women, newborns, children, and adolescents during the COVID-19 pandemic in countries of Americas]. / Estrategias de servicios de salud en mujeres, recién nacidos/as, niños/as y adolescentes durante la pandemia de COVID-19 en países de las Américas.

The article analyzes the perceived challenges and strategies implemented in five Latin American and Caribbean countries to ensure continuity of care and access to health services for women, newborns, children, and adolescents during the COVID-19 pandemic. The study corresponds to a quick assessment based on semi-structured interviews with key informants in countries selected by convenience: Colombia, Ecuador, Guatemala, Grenada, and the Dominican Republic. Interviews were conducted with 23 key informants: (a) decision makers at the national and/or subnational level, (b) healthcare professionals, and (c) representatives of civil society organizations; from December 2020 to January 2021. Among the findings, at the beginning of the pandemic, priority was given to the COVID-19 care, with measures to limit the flow of people to health facilities in the countries involved, closing or limiting outpatient visits and restricting care schedule. For women, this affected family planning services and access to contraceptive methods, implying a reduction in prenatal check-ups. As a result of this deinstitutionalization of care, among newborns, a decrease in pediatric check-ups, a decrease in timely immunization and late detection of pathologies or growth problems were reported. Among adolescents, a strong restriction of family planning services, the limitation of other friendly counseling spaces and difficulties in accessing contraceptives were observed.

El artículo analiza los desafíos percibidos y las estrategias implementadas en cinco países de América Latina y el Caribe para garantizar la continuidad de los cuidados y el acceso a servicios de salud de mujeres, recién nacidos/as, niños/as y adolescentes durante la pandemia por COVID-19. El estudio corresponde a una evaluación rápida basada en entrevistas semi-estructuradas a informantes clave de países seleccionados por conveniencia: Colombia, Ecuador, Guatemala, Granada y República Dominicana. Se realizaron entrevistas con 23 informantes clave: (a) referentes de la toma de decisión a nivel nacional y/o subnacional, (b) referentes de servicios de salud, y (c) representantes de organizaciones de la sociedad civil, durante diciembre de 2020 y enero de 2021. Entre los hallazgos, al inicio de la pandemia se priorizó la atención del COVID-19, con medidas para limitar la afluencia de personas a los establecimientos de salud en los países involucrados, procediendo al cierre o limitación de consultas externas y restricción de horarios de atención. Para las mujeres, esto impactó en los servicios de planificación familiar y el acceso a métodos anticonceptivos, e implicó una reducción de los controles prenatales. Por esta desinstitucionalización de la atención, entre recién nacidos/as fue reportada una disminución de los controles pediátricos, una disminución de su vacunación oportuna y una detección tardía de patologías o problemas de crecimiento. Entre adolescentes, se señaló una fuerte restricción de los servicios de planificación familiar, la limitación de otros espacios amigables de consejería y dificultades para acceder a anticonceptivos.

O artigo analisa os desafios observados e as estratégias implementadas em cinco países da América Latina e do Caribe para garantir a continuidade do atendimento e o acesso aos serviços de saúde para mulheres, recém-nascidos/as, crianças e adolescentes durante a pandemia de COVID-19. O estudo é uma avaliação rápida baseada em entrevistas semiestruturadas com informantes-chave em países selecionados por conveniência: Colômbia, Equador, Guatemala, Granada e República Dominicana. Foram realizadas entrevistas com 23 informantes-chave: (a) tomadores de decisão em nível nacional e/ou subnacional, (b) prestadores de serviços de saúde e (c) representantes de organizações da sociedade civil; durante dezembro de 2020 e janeiro de 2021. Entre as conclusões encontrou-se que, no início da pandemia, foi dada prioridade à COVID-19, com medidas para limitar o fluxo de pessoas às instalações de saúde nos países envolvidos, fechando ou limitando as consultas ambulatoriais e restringindo o horário de atendimento. Para as mulheres, a medida impactou os serviços de planejamento familiar e o acesso à contracepção, significando uma redução nos check-ups pré-natais. Como resultado desta desinstitucionalização dos cuidados, uma diminuição dos check-ups pediátricos, uma diminuição das vacinações no período correto e uma detecção tardia de patologias ou problemas de crescimento foram relatados entre os/as recém-nascidos/as. Entre os adolescentes, foi observada uma restrição severa dos serviços de planejamento familiar, a limitação de acesso a espaços de aconselhamento amigável e dificuldades de acesso a contraceptivos.

Equity throughout the life course and the evolving role of the Pan American Health Organization / Equidad a lo largo del curso de vida y la evolución del papel de la Organización Panamericana de la Salud / Equidade ao longo da vida e a evolução do papel da Organização Pan-Americana da Saúde

ABSTRACT The objective of this article is to summarize the evolution of the regional commitments of the Pan American Health Organization (PAHO) on health promotion and strategies to improve the health and well-being of women, children, adolescents, and older persons. PAHO regional strategies approved by Member States in the last 20 years are used as the main source of information. The article presents the challenges of making health promotion a public health strategy widely applied in the Region of the Americas and the efforts to renew Member States' collective actions. The article also describes current PAHO efforts to include the positive aspects of health (i.e., well-being, optimal development, and functional ability) and the life course approach as opportunities to advance equity. The article reflects on immunization as a public good and the urgency to address the current challenges as a core element of the regional efforts to transform health systems after more than two years of the COVID-19 pandemic.

RESUMEN El objetivo de este artículo es resumir la evolución de los compromisos regionales de la Organización Panamericana de la Salud (OPS) en materia de promoción de la salud y estrategias para mejorar la salud y el bienestar de mujeres, niños y niñas, adolescentes y personas mayores. Se han empleado como principal fuente de información las estrategias regionales de la OPS aprobadas por los Estados Miembros en los últimos 20 años. En el artículo se presentan los desafíos de convertir la promoción de la salud en una estrategia de salud pública de amplia ejecución en la Región de las Américas y los esfuerzos para renovar las medidas colectivas de los Estados Miembros. Asimismo, se describe la labor actual de la OPS para incluir los aspectos positivos de la salud (como el bienestar, el desarrollo óptimo y la capacidad funcional) y el enfoque del curso de vida como oportunidades para fomentar la equidad. Finalmente, se reflexiona sobre la inmunización como bien público y la urgencia de abordar los desafíos actuales como elemento central de los esfuerzos regionales para transformar los sistemas de salud tras más de dos años de pandemia de COVID-19.

RESUMO O objetivo deste artigo é resumir a evolução dos compromissos regionais da Organização Pan-Americana da Saúde (OPAS) relativos à promoção da saúde e estratégias para melhorar a saúde e o bem-estar de mulheres, crianças, adolescentes e pessoas idosas. As estratégias regionais da OPAS aprovadas pelos Estados Membros nos últimos 20 anos são a principal fonte de informação. O artigo apresenta os desafios enfrentados para fazer da promoção da saúde uma estratégia de saúde pública amplamente aplicada na Região das Américas e os esforços para renovar as ações coletivas dos Estados Membros. O artigo também descreve os atuais esforços da OPAS para incluir os aspectos positivos da saúde (isto é, bem-estar, desenvolvimento ideal e habilidade funcional) e a abordagem de curso da vida como oportunidades para promover a equidade. O artigo faz reflexões sobre a imunização como um bem público e a urgência de abordar os desafios atuais como um elemento central dos esforços regionais para transformar os sistemas de saúde após mais de dois anos da pandemia de COVID-19.

Estrategias de servicios de salud en mujeres, recién nacidos/as, niños/as y adolescentes durante la pandemia de COVID-19 en países de las Américas / Strategies for health services in women, newborns, children, and adolescents during the COVID-19 pandemic in countries of Americas / Estratégias de serviços de saúde para mulheres, recém-nascidos/as, crianças e adolescentes durante a pandemia de COVID-19 nos países das Américas

El artículo analiza los desafíos percibidos y las estrategias implementadas en cinco países de América Latina y el Caribe para garantizar la continuidad de los cuidados y el acceso a servicios de salud de mujeres, recién nacidos/as, niños/as y adolescentes durante la pandemia por COVID-19. El estudio corresponde a una evaluación rápida basada en entrevistas semi-estructuradas a informantes clave de países seleccionados por conveniencia: Colombia, Ecuador, Guatemala, Granada y República Dominicana. Se realizaron entrevistas con 23 informantes clave: (a) referentes de la toma de decisión a nivel nacional y/o subnacional, (b) referentes de servicios de salud, y (c) representantes de organizaciones de la sociedad civil, durante diciembre de 2020 y enero de 2021. Entre los hallazgos, al inicio de la pandemia se priorizó la atención del COVID-19, con medidas para limitar la afluencia de personas a los establecimientos de salud en los países involucrados, procediendo al cierre o limitación de consultas externas y restricción de horarios de atención. Para las mujeres, esto impactó en los servicios de planificación familiar y el acceso a métodos anticonceptivos, e implicó una reducción de los controles prenatales. Por esta desinstitucionalización de la atención, entre recién nacidos/as fue reportada una disminución de los controles pediátricos, una disminución de su vacunación oportuna y una detección tardía de patologías o problemas de crecimiento. Entre adolescentes, se señaló una fuerte restricción de los servicios de planificación familiar, la limitación de otros espacios amigables de consejería y dificultades para acceder a anticonceptivos.

The article analyzes the perceived challenges and strategies implemented in five Latin American and Caribbean countries to ensure continuity of care and access to health services for women, newborns, children, and adolescents during the COVID-19 pandemic. The study corresponds to a quick assessment based on semi-structured interviews with key informants in countries selected by convenience: Colombia, Ecuador, Guatemala, Grenada, and the Dominican Republic. Interviews were conducted with 23 key informants: (a) decision makers at the national and/or subnational level, (b) healthcare professionals, and (c) representatives of civil society organizations; from December 2020 to January 2021. Among the findings, at the beginning of the pandemic, priority was given to the COVID-19 care, with measures to limit the flow of people to health facilities in the countries involved, closing or limiting outpatient visits and restricting care schedule. For women, this affected family planning services and access to contraceptive methods, implying a reduction in prenatal check-ups. As a result of this deinstitutionalization of care, among newborns, a decrease in pediatric check-ups, a decrease in timely immunization and late detection of pathologies or growth problems were reported. Among adolescents, a strong restriction of family planning services, the limitation of other friendly counseling spaces and difficulties in accessing contraceptives were observed.

O artigo analisa os desafios observados e as estratégias implementadas em cinco países da América Latina e do Caribe para garantir a continuidade do atendimento e o acesso aos serviços de saúde para mulheres, recém-nascidos/as, crianças e adolescentes durante a pandemia de COVID-19. O estudo é uma avaliação rápida baseada em entrevistas semiestruturadas com informantes-chave em países selecionados por conveniência: Colômbia, Equador, Guatemala, Granada e República Dominicana. Foram realizadas entrevistas com 23 informantes-chave: (a) tomadores de decisão em nível nacional e/ou subnacional, (b) prestadores de serviços de saúde e (c) representantes de organizações da sociedade civil; durante dezembro de 2020 e janeiro de 2021. Entre as conclusões encontrou-se que, no início da pandemia, foi dada prioridade à COVID-19, com medidas para limitar o fluxo de pessoas às instalações de saúde nos países envolvidos, fechando ou limitando as consultas ambulatoriais e restringindo o horário de atendimento. Para as mulheres, a medida impactou os serviços de planejamento familiar e o acesso à contracepção, significando uma redução nos check-ups pré-natais. Como resultado desta desinstitucionalização dos cuidados, uma diminuição dos check-ups pediátricos, uma diminuição das vacinações no período correto e uma detecção tardia de patologias ou problemas de crescimento foram relatados entre os/as recém-nascidos/as. Entre os adolescentes, foi observada uma restrição severa dos serviços de planejamento familiar, a limitação de acesso a espaços de aconselhamento amigável e dificuldades de acesso a contraceptivos.

Costo-efectividad de tratamientos ambulatorios para la pérdida de peso, en adultos mexicanos / Cost-effectiveness in outpatient treatments for weight loss in Mexican adults

Resumen Objetivo: Identificar la mejor intervención costo-efectividad para el tratamiento de obesidad grado I y II, en el primer nivel de atención para población sin seguridad social, que requiera los servicios del Instituto de Salud y Bienestar (INSABI) Material y Métodos: Se realizó un análisis de costo-efectividad desde la perspectiva del proveedor. Se diseñaron y calcularon los costos de tres tratamientos para la obesidad I y II en usuarios del primer nivel de atención a la salud que carecen de seguridad social, en el municipio de Coatetelco, Morelos. Cada tratamiento fue estimado para el periodo de un año. Los indicadores de efectividad fueron obtenidos a través de estudios previos con características similares a las intervenciones diseñadas. Resultados: La intervención que presento un mayor costo, fue el tratamiento farmacológico con $88,899.26 USD, seguida del tratamiento nutricional con un costo de $31,647.57 USD y $57,189.49 USD en el tratamiento integral. El coeficiente de efectividad obtenido fue de 0.1906 para el tratamiento nutricional, seguido del tratamiento farmacológico con 0.2168 y 0.2531 en el tratamiento integral. Conclusiones: El tratamiento nutricional es la mejor intervención costo- efectividad en pacientes con obesidad grado I y II que carecen de seguridad social y que reciben seguimiento en el primer nivel de atención a la salud. La inversión en estos tratamientos puede contribuir a disminuir los factores de riesgo para el desarrollo de enfermedades crónicas en México.

Abstract Objective: To identify the most cost-effective intervention for the treatment of grade I and II obesity in the first level of care for a population without social security that requires the services of the Institute of Health and Wellbeing (INSABI). Material and Methods: A cost-effectiveness analysis was carried out from the provider's perspective. The costs of three treatments for obesity I and II in users of the first level of health care who lack social security were designed and calculated in the municipality of Coatetelco, Morelos. Each treatment was estimated for a period of one year. The effectiveness indicators were obtained through previous studies with characteristics similar to the designed interventions. Results: The intervention that presented the highest cost was drug treatment with $ 88,899.26 USD, followed by nutritional treatment with a cost of $ 31,647.57 USD and $ 57,189.49 USD in comprehensive treatment. The coefficient of effectiveness obtained was 0.1906 for nutritional treatment, followed by pharmacological treatment with 0.2168 and 0.2531 in comprehensive treatment. Conclusions: Nutritional treatment is the most cost-effective intervention in patients with grade I and II obesity who lack social security is nutritional treatment and who receive care at the first level of health care. Investing in these treatments can help reduce risk factors for the development of chronic diseases in Mexico.

Time-efficiency assessment of guided toric intraocular lens cataract surgery: pilot study.

PURPOSE: To compare the time spent on toric intraocular lens (IOL) implantation during cataract surgery using a manual-marking vs a digital image-guided system (t Verion) for toric IOL alignment. SETTING: Instituto Oftalmológico Quirónsalud ophthalmology clinic, A Coruña, Spain. DESIGN: Experimental and longitudinal study. METHODS: A total of 98 eyes of 65 participants (68.2 ± 12.2 years) were divided into 2 groups: 49 eyes operated with toric IOL alignment using a manual-marking technique (manual group) and another 49 eyes operated using image-guided marking (Verion group). The primary variable for comparison between both groups was cataract surgery time. Other outcomes such as toric IOL misalignment, spherical equivalent, astigmatism, uncorrected distance visual acuity, and corrected distance visual acuity were also measured. RESULTS: The total cataract surgery time was 2:09 minutes shorter (P < .001) with the Verion system (12:12 ± 2:20 in 49 eyes operated) compared with the surgical procedure performed using manual marking (15:27 ± 3:04 in 49 eyes operated). One month after surgery, there were no statistical differences in terms of toric IOL misalignment between the Verion (3.38 ± 2.95 degrees) and the manual group (4.66 ± 3.95 degrees). No statistical differences were observed between groups for refractive and visual outcomes (P ≥ .05). CONCLUSIONS: The cataract surgery time was reduced when the procedure was assisted using the Verion system to align the IOL compared with manual marking, maintaining the same efficacy in terms of toric IOL misalignment, residual refraction, and visual acuity.

Information and communication technologies in neonatal health.

OBJECTIVES: To identify scientific evidence on the use and results of information and communication technologies for the improvement of neonatal health in general or specific health problems or interventions, and to describe the type of intervention and its results. METHODS: A systematic review of the available evidence was performed. The search was carried out in peer-reviewed journals between January 1, 2008 and April 30, 2018, in English and Spanish. The searched key terms were (health informatics OR telemedicine OR mHealth) AND (newborn OR newborn care OR neonatal care). RESULTS: From a total of 305 articles initially identified, 10 articles fulfilled the inclusion criteria. The main domains of eHealth identified as applied to neonatal health were telemedicine (3 studies), eLearning (1 study) and mHealth (7 studies). Target population were health care providers or parents. The studies aimed at diagnosis, provision of health care and training, promoting adherence to interventions in parents or improving quality of care. CONCLUSIONS: The use of eHealth in general and specifically focused on neonatal health shows important possibilities for development and expansion, given the advances and present needs, and should be considered a key tool for the reduction of inequalities.

OBJETIVOS: Identificar la evidencia científica sobre el uso y los resultados de las tecnologías de la información y la comunicación para mejorar la salud neonatal en general o problemas de salud o intervenciones específicos, y describir el tipo de intervención y sus resultados. MÉTODOS: Se realizó una revisión sistemática de la evidencia disponible. La búsqueda se llevó a cabo en revistas revisadas por pares entre el 1 de enero de 2008 y el 30 de abril de 2018, en español e inglés. Los términos clave de la búsqueda fueron (health informatics OR telemedicine OR mHealth) AND (newborn OR newborn care OR neonatal care). RESULTADOS: De un total de 305 artículos identificados inicialmente, 10 artículos cumplieron los criterios de inclusión. Los principales dominios de la eSalud aplicados a la salud neonatal fueron la telemedicina (3 estudios), el aprendizaje electrónico (1 estudio) y la salud móvil (7 estudios). La población destinataria consistió en los proveedores de atención de la salud o los padres. Los estudios tenían por objeto el diagnóstico, la prestación de atención sanitaria y la capacitación, la promoción del cumplimiento de las intervenciones en los padres o la mejora de la calidad de la atención. CONCLUSIONES: El uso de la eSalud en general, y específicamente en la salud neonatal, muestra importantes posibilidades de desarrollo y expansión, dados los avances y las necesidades actuales, y debería considerarse un instrumento clave para la reducción de las desigualdades.

Exploring Phytotherapeutic Alternatives for Obesity, Insulin Resistance and Diabetes Mellitus.

At present, the pathologic spectrum of obesity-insulin resistance (IR)-diabetes mellitus (DM) represents not only a pressing matter in public health but also a paramount object of study in biomedical research, as they constitute major risk factors for cardiovascular disease (CVD), and other chronic non-communicable diseases (NCD). Phytotherapy, the use of medicinal herbs (MH) with treatment purposes, offers a wide array of opportunities for innovation in the management of these disorders; mainly as pharmacological research on small molecules accumulates. Several MH has displayed varied mechanisms of action relevant to the pathogenesis of obesity, IR and DM, including immunological and endocrine modulation, reduction of inflammation and oxidative stress (OS), regulation of appetite, thermogenesis and energy homeostasis, sensitisation to insulin function and potentiation of insulin release, among many others. However, the clinical correlates of these molecular phenomena remain relatively uncertain, with only a handful of MH boasting convincing clinical evidence in this regard. This review comprises an exploration of currently available preclinical and clinical research on the role of MH in the management of obesity, IR, and DM.

An analysis of three levels of scaled-up coverage for 28 interventions to avert stillbirths and maternal, newborn and child mortality in 27 countries in Latin America and the Caribbean with the Lives Saved Tool (LiST).

BACKGROUND: Action to avert maternal and child mortality was propelled by the Millennium Development Goals (MDGs) in 2000. The Latin American and Caribbean (LAC) region has shown promise in achieving the MDGs in many countries, but preventable maternal, neonatal and child mortality persist. Furthermore, preventable stillbirths are occurring in large numbers in the region. While an effective set of maternal, newborn and child health (MNCH) interventions have been identified, they have not been brought to scale across LAC. METHODS: Baseline data for select MNCH interventions for 27 LAC countries that are included in the Lives Saved Tool (LiST) were verified and updated with survey data. Three LiST projections were built for each country: baseline, MDG-focused, and All Included, each scaling up a progressively larger set of interventions for 2015 - 2030. Impact was assessed for 2015 - 2035, comparing annual and total lives saved, as projected by LiST. RESULTS: Across the 27 countries 235,532 stillbirths, and 752,588 neonatal, 959,393 under-five, and 60,858 maternal deaths would be averted between 2015 and 2035 by implementing the All-Included intervention package, representing 67 %, 616 %, 807 % and 101 % more lives saved, respectively, than with the MDG-focused interventions. 25 % neonatal deaths averted with the All-Included intervention package would be due to asphyxia, 42 % from prematurity and 24 % from sepsis. CONCLUSIONS: Our modelling suggests a 337 % increase in the number of lives saved, which would have enormous impacts on population health. Further research could help clarify the impacts of a comprehensive scale-up of the full range of essential MNCH interventions we have modelled.

Progress in reducing inequalities in reproductive, maternal, newborn,' and child health in Latin America and the Caribbean: an unfinished agenda.

OBJECTIVE: To expand the "Countdown to 2015" analyses of health inequalities beyond the 75 countries being monitored worldwide to include all countries in Latin America and the Caribbean (LAC) that have adequate data available. METHODS: Demographic and Health Surveys and Multiple Indicator Cluster Surveys were used to monitor progress in health intervention coverage and inequalities in 13 LAC countries, five of which are included in the Countdown (Bolivia, Brazil, Guatemala, Haiti, and Peru) and eight that are not (Belize, Colombia, Costa Rica, Dominican Republic, Guyana, Honduras, Nicaragua, and Suriname). The outcomes included neonatal and under-5 year mortality rates, child stunting prevalence, and the composite coverage index-a weighted average of eight indicators of coverage in reproductive, maternal, newborn, and child health. The slope index of inequality and concentration index were used to assess absolute and relative inequalities. RESULTS: The composite coverage index showed monotonic patterns over wealth quintiles, with lowest levels in the poorest quintile. Under-5 and neonatal mortality as well as stunting prevalence were highest among the poor. In most countries, intervention coverage increased, while under-5 mortality and stunting prevalence fell most rapidly among the poor, so that inequalities were reduced over time. However, Bolivia, Guatemala, Haiti, Nicaragua, and Peru still show marked inequalities. Brazil has practically eliminated inequalities in stunting. CONCLUSIONS: LAC countries presented substantial progress in terms of reducing inequalities in reproductive, maternal, newborn, and child health interventions, child mortality, and nutrition. However, the poorest 20% of the population in most countries is still lagging behind, and renewed actions are needed to improve equity.

Progress in reducing inequalities in reproductive, maternal, newborn,' and child health in Latin America and the Caribbean: an unfinished agenda / Avances en la reducción de las desigualdades en materia de salud reproductiva, materna, neonatal e infantil en América Latina y el Caribe: un programa inacabado

OBJECTIVE: To expand the "Countdown to 2015" analyses of health inequalities beyond the 75 countries being monitored worldwide to include all countries in Latin America and the Caribbean (LAC) that have adequate data available. METHODS: Demographic and Health Surveys and Multiple Indicator Cluster Surveys were used to monitor progress in health intervention coverage and inequalities in 13 LAC countries, five of which are included in the Countdown (Bolivia, Brazil, Guatemala, Haiti, and Peru) and eight that are not (Belize, Colombia, Costa Rica, Dominican Republic, Guyana, Honduras, Nicaragua, and Suriname). The outcomes included neonatal and under-5 year mortality rates, child stunting prevalence, and the composite coverage index-a weighted average of eight indicators of coverage in reproductive, maternal, newborn, and child health. The slope index of inequality and concentration index were used to assess absolute and relative inequalities. RESULTS: The composite coverage index showed monotonic patterns over wealth quintiles, with lowest levels in the poorest quintile. Under-5 and neonatal mortality as well as stunting prevalence were highest among the poor. In most countries, intervention coverage increased, while under-5 mortality and stunting prevalence fell most rapidly among the poor, so that inequalities were reduced over time. However, Bolivia, Guatemala, Haiti, Nicaragua, and Peru still show marked inequalities. Brazil has practically eliminated inequalities in stunting. CONCLUSIONS: LAC countries presented substantial progress in terms of reducing inequalities in reproductive, maternal, newborn, and child health interventions, child mortality, and nutrition. However, the poorest 20% of the population in most countries is still lagging behind, and renewed actions are needed to improve equity.

OBJETIVO: Extender los análisis de la "Cuenta Regresiva para 2015" de las desigualdades en materia de salud más allá de los 75 países sometidos a vigilancia en todo el mundo para incluir a todos los países de América Latina y el Caribe (ALC) que disponen de datos adecuados. MÉTODOS: Se utilizaron encuestas de demografía y salud y encuestas agrupadas de indicadores múltiples para vigilar el progreso de la cobertura de las intervenciones de salud y de las desigualdades en 13 países de ALC, 5 de ellos incluidos en la Cuenta Regresiva (Bolivia, Brasil, Guatemala, Haití y Perú) y 8 no incluidos (Belice, Colombia, Costa Rica, Guyana, Honduras, Nicaragua, República Dominicana y Suriname). Los resultados incluyeron las tasas de mortalidad neonatal y en menores de 5 años, la prevalencia del retraso del crecimiento en niños y el índice compuesto de cobertura (un promedio ponderado de 8 indicadores de cobertura en materia de salud reproductiva, materna, neonatal e infantil. Para evaluar las desigualdades absolutas y relativas, se emplearon el índice de desigualdad de la pendiente y el índice de concentración. RESULTADOS: El índice compuesto de cobertura mostró patrones monotónicos en función de los quintiles de riqueza, con los niveles más bajos en el quintil más pobre. La mortalidad neonatal y en menores de 5 años, así como la prevalencia del retraso del crecimiento, fueron más elevadas entre los pobres. En la mayor parte de los países aumentó la cobertura de las intervenciones, mientras que la mortalidad en menores de 5 años y la prevalencia del retraso del crecimiento disminuyeron más rápidamente entre los pobres, de manera que las desigualdades se redujeron con el transcurso del tiempo. Sin embargo, en Bolivia, Guatemala, Haití, Nicaragua y Perú aún se observan marcadas desigualdades. Brasil prácticamente ha eliminado las desigualdades en cuanto a retraso del crecimiento. CONCLUSIONES: Los países de ALC mostraron avances considerables en la reducción de las desigualdades con respecto a las intervenciones de salud reproductiva, materna, neonatal e infantil, y en materia de mortalidad y nutrición infantil. Sin embargo, el 20% más pobre de la población en la mayor parte de los países sigue quedándose a la zaga, y son necesarias iniciativas renovadas para mejorar la equidad.

Maternal and congenital syphilis in selected Latin America and Caribbean countries: a multi-country analysis using data from the Perinatal Information System.

UNLABELLED: Background Maternal syphilis has an important impact on reproductive health. In 2010, World Health Organization (WHO)/Pan American Health Organization (PAHO) member countries approved the Strategy and Plan of Action for Elimination of Mother-to-Child Transmission of HIV and Congenital Syphilis in the Americas by 2015. This paper aims to describe epidemiological and programmatic characteristics related to maternal and congenital syphilis in selected countries of Latin America and Caribbean for the period 2010-12. METHODS: The report is based on a multi-country, quantitative and qualitative analysis from data collected from several sources, representing a compilation of country reports from nine countries as part of the 2012 mid-term evaluation of the Strategy. Data was collected based on standardised procedures at country level. RESULTS: Results are variable among countries. All countries have a strategic national plan to eliminate congenital syphilis, with some distinct characteristics for each country. Protocols and guidelines for the management and treatment of maternal and congenital syphilis in all countries were updated between 2011 and 2013. A high rate of missing information for all countries for some indicators was noticed. CONCLUSIONS: The main limitation of the analyses is the huge amount of missing data. Countries must continue to be supported to build capacity for collecting high-quality data on intervention coverage and inequities, and to use it as a basis for decisions about how best to reach women and children with interventions. A high level political commitment is necessary to put into practice the Regional Initiative to Eliminate Congenital Syphilis, with the support of Health Ministries.